chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient got pneumovax at 1000am 08/22/03 and came back at 1430pm complainted that left arm swollen and painful to raise up.  Patient was seen by Dr and was given Depo medrol 40mg and Kenalog 40mg Im and also a med dose pack to go home with.  Patient was instructed to come to urgent care center the next day 08/23/03 for check up on dismiss.
NO TASTE; DIARRHEA; FEELING SICK; FEVER; NAUSEA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 16-MAR-2021 11:30 a.m. (vaccinated at right arm) for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 17-MAR-2021, the subject experienced no taste. On 17-MAR-2021, the subject experienced diarrhea. On 17-MAR-2021, the subject experienced feeling sick. On 17-MAR-2021, the subject experienced fever. On 17-MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, nausea, no taste, diarrhea and feeling sick was not reported. This report was non-serious.
Red blotch that itches at injection site.  Also had diarrhea, vomiting, body aches
One hour after shot ached all over, chills, fever 103. Saw medical doctor next day 12/15 blood work ordered and prednisone ordered for 5 days. No reaction at injection site. Experiencing chest pain and back pain. Tylenol as needed to decrease pain. Saturday 12/16 face broke out in rash. Medical doctor contacted 12/17 continue prednisone call if problems persist.
This spontaneous report as received from a medical assistant, via company representative, refers to a patient of unknown age and gender. Medical history and current conditions were not reported. On an unknown date, the patient was vaccinated with a second dose of ZOSTAVAX, subcutaneous (lot number and expiration date were not reported) a few months after the patient received the first dose. No adverse effects were reported. Additional information has been requested.
Immediately after given vaccine - feeling of lump in throat. Unable to swallow, shortness of breath, rapid heart beat, flush feeling, intense shaking (especially in legs), pain in chest, lightheadedness, dizziness (ruled anxiety) and was monitored for 40 minutes. Was given orange juice and water and allowed to remove mask to catch breath. Almost everyday since this event, the same event keeps repeating it self (almost daily for 3 weeks). I am unable to control these episodes. Emergency department (ED) has been called and I have gone to see my nurse practitioner. Been trying to make an appointment with my doctor for this week.  I have lost 5 pounds (down to 105 lbs. so I can't afford to loose more weight) since this first happened and I have also lost my appetite and unable to function normally.
Node is bleeding. Happened about 7 times. First 3-4 times it happened was during the week of April 21st to April 27th. Next nosebleed occurred on April 2 around 6-7:30 pm (this one the blood was dried when I noticed). Another nosebleed occurred on April 3 at around 12:30 pm (this one was a little runny but not gushing, not much blood). Last nosebleed to occur was on April 5 around 3 pm (this one was dried blood). 2 of the nosebleed have been runny (not much blood and not gushing) and the rest have been noticed as dried blood in the nose. Right nostril is bleeding a little more than left nostril in each of the cases.
Child passed out, fell down off of a step face first and was rigid on the ground, unresponsive for less than 1 minute. Came to, became responsive after placing cold washcloth on forehead and calling her name. Child also lost control of urine while she passed out. Child was able to sit up and walk to the nurses room shortly after regaining consciousness and was sitting reading a book when her mother was called.
Patient age 17 was administered Moderna on the mobile unit.  Age limit for Moderna is 18.
Shortness of breath, weakness, heart palpitations. and got diagnosed with both bronchitis and pneumonia.
2-27-08 patient called and complained of "ache" at injection site.  No redness, no swelling - to take Motrin or Tylenol.  3-1-08 patient seen - localized reaction secondary to tetanus shot.  3-10-08 patient called - still in pain - wakes her up at night - states range of motion in arm about 6".  To be seen tonight by doctor.
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/29/2021 and 3/4/2021. Patient presented to emergency department complaining of shortness of breath. Patient was admitted for COVID-19 pneumonia and hypoxia requiring supplemental oxygen therapy. Patient received: ascorbic acid, broad spectrum antibiotics, methylprednisolone, remdesivir, tocilizumab. Patient's respiratory status rapidly declined and patient became encephalpathic, hypernatremic, and bradycardic. Patient was transitioned to comfort care and expired 10/8/2021 at 1935.
Two things; right ovarian cyst that was painful (over one year post menapause) that was confirmed by ultrasound and vaginal ultrasound.  Shingles  - on right side -- painful rash (PCP office took photos) and nerve pain.  Still on Gabapentin for the nerve pain.
Numbness on 1/2 of the face, left and drove home - resolved by the time she was home.
Janssen COVID?19 Vaccine EUA  12 hours of severe chills, aches, very bad headache and jaw ache, possibly fever  beginning 9 hours after dose.  Felt almost back to normal after 12 hours.
Will order labs for newly detected COVID, and begin Remdesivir   presented to the ED from home with for worsening shortness of breath.
No Additional AE; MMR II vaccine was administered after undergoing temperature excursions; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Patient's concurrent conditions, medical history and concomitant medications were not provided.     On 12-JAN-2022, the patient was vaccinated with first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant human albumin (rHA) (M-M-R II) (lot # T027914 and expiration date reported 18-AUG-2022), 0.5 milliliter for prophylaxis after undergoing temperature excursions (Product storage error).  The temperature of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant human albumin (rHA) (M-M-R II) was 9.6 Celsius 47 and there were previous temperature excursions on 18-DEC-2021 was 13.7 Celsius for 6 hours. No additional AE. No PQC.  This is one of several reports received from the same reporter.
Patient underwent his Covid booster (3rd vaccine) and Pneumococcal/ Varicella catch-up vaccination on 9/29/21. Next morning 9/30 had mild soreness at Left shoulder site, mild chills.  Subsequently severe left shoulder swelling, erythema, severe pain and tenderness to palpation developed 10/1/21 AM and he presented to the Emergency room. Had evidence of Systemic Inflammatory response syndrome manifested by Fever (temp 101), hypotension (77/48), Leukocytosis (WBC 17.2), tachycardia (HR 124), tachypnea (RR 24) on arrival, requiring hospitalization, intensive fluid resuscitation (5 L saline/ LR), IV Antibiotics for presumed infectious process (cellulitis). Lactate 2.5. Subsequently hospitalization remarkable for initial bradycardia HR 48, hypotension requiring further fluid administration. Had one run of 12 seconds of Non-sustained Ventricular Tachycardia on the afternoon of 10/2/21 with some chest "fluttering", no pain. No other chest pain experienced otherwise. was able to be discharged home on 10/3/21 in stable condition
Accidental Inoculation to left side of neck and upper shoulder. (upper trapezius area)
No additional AEs; HCP called in to report a temperature excursion and also reported that the vaccine, ROTATEQ was administered.; This spontaneous report was received from nurse referring to an unknown age and girder patient. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant therapies were not reported.  On 01-AUG-2022, the patient was vaccinated with improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, lot number 1837118, which was determined to be valid, with an expiration date: 25-MAR-2023, administered orally for prophylaxis (strength, dose, anatomical site were not provided) (product storage error).  No additional adverse event (AE) information was provided (no adverse event).
Client came to a first dose Moderna clinic. Was told 2 different times that it was a first dose Moderna clinic. Was given Moderna EUA information. Was given a blank Immunization Vaccination Record ( except for her nmae and D.O.B) indicating that it was a first dose as there was no other information on it. Was told by the nurse she was getting Moderna.  Client does have a speech impediment so does not talk a lot. However, understands information when spoken to. After the vaccine was given , nurse told client she needs to set up her second dose.  At that point ,she pulled out  a different vaccine record that she had in her purse. On that record it showed she had received a Pfizer vaccine on 01/29/ 21. Client immediately understood that she had received a different vaccine. She realized she had not let anyone know she had received a dose before and that it was not Moderna. Let her know due with current guidelines she would not need a repeat dose but was considered complete for COVID vaccinations.
After 3 days of immunization, the baby girl was confused and weak. For around an hour she had general weakness, sleepiness and the eyes were roll back. She was sent to the emergency room and there she recovered.
THE PATIENT RECEIVED THE VACCINE AROUND 2 P.M. ON 11/5/12 IN THE PHARMACY SHE WORKS AT AND SHE CONTINUED TO WORK THAT DAY. BY THE TIME SHE GOT OFF WORK AND GOT HOME AROUND 7 P.M. HER ARM WAS RED, SWOLLEN, HARD AND VERY INFLAMMED. IT WAS ALSO HOT TO THE TOUCH. THIS REACTION COVERED THE MAJORITY OF HER UPPER LEFT ARM. TODAY IS 11/8/12 AND THE REACTION HAS JUST BARELY STARTED TO GO DOWN IN SIZE. ON THE NIGHT OF 11/5/12 THE PATIENT ALSO EXPERIENCED FLU-LIKE SYMPTOMS ALONG WITH DIARRHEA, NAUSEA AND VOMITING. THESE SYMPTOMS HAVE STARTED TO RESOLVE SLIGHTLY TODAY 11/8/12.
Aches; bronchitis; Chills; fever; a few acute muscle cramps; This is a spontaneous report received from a contactable consumer, the patient. A 65-years-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via an unspecified route of administration in the left arm on 15Mar2021 at 10 : 00AM (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient included hiatal hernia from an unknown date. Concomitant medication included nexium, synthroid and cymbalta on an unspecified date for an unspecified reason. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6210) via an unspecified route of administration in the left arm on 22Feb2021 for COVID-19 immunisation. The patient did not have any allergies to food, medications, or other products Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient was not tested positive for COVID-19. The patient experienced aches, bronchitis, acute muscle cramps, chills and fever on 15Mar2021. The patient did not receive any treatment for the reported events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events aches, bronchitis, acute muscle cramps, chills and fever was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.
A report has been received from a Health Professional concerning a 15 year old, female subject, who had been receiving Nasal FLUMIST QUADRIVALENT (INTRANASAL). FLUMIST QUADRIVALENT (INTRANASAL) started on 16-Jan-2014. Inadvertently was given expired FLUMIST QUADRIVALENT which started on 16-Jan-2014. The outcome of the event of gave expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious by the reporter.
At approximately 8 hours post vaccine I began to have Sudden onset bilateral joint pain mostly in my elbows but knees and hips as well. Then my neck started really hurting. I got a headache. Nausea and powerful chills that made my whole body violently shake. My core temperature Dropped to below 96, high 95s. Over a period of two hours I have stabilized my body temperature, the shaking has stopped. However the headache and muscle aches persist. No respiratory symptoms have developed.  I feel as if I am recovering, over a period of about four hours.
patient reported redness and said injection site was warm to the touch; also rash on trunk, general malaise for 2-3 days
passed out; terrible headache; still some body aches; general bad feeling all over; nausea/tremendous chills and nausea; tremendous chills and nausea; low grade fever 99.5; This is a spontaneous report from a contactable consumer (patient). A 48-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in Left arm (at age of 48-year-old) on 02Feb2021 at 10:30 AM as a single dose for COVID-19 immunisation, lot number: EL9262. Medical history included high cholesterol and allergies to some seaweeds. Patient received first vaccine dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 14Jan2021 via an unspecified route of administration in Left arm (at age of 48-year-old) for COVID-19 immunisation, lot number: EL3246. Concomitant medications in two weeks prior to the vaccination included atorvastatin and multi- vitamin. Patient did not receive other vaccine in four weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Patient started about 12 hours after getting vaccinated (reported as 02Feb2021 at 10:00 PM) with a general bad feeling all over, 15 hours after (03Feb2021 at 01:00 AM) patient got out of bed because of nausea and passed out, his wife found he on the floor. Patient had tremendous chills and nausea with a low grade fever 99.5 for several more hours, maybe 6 hours, (onset date 02Feb2021) the next morning patient had a terrible headache and still some body aches. Patient was treated with extra strength paracetamol (TYLENOL) and ondansetron (ZOFRAN). Since the vaccination patient had not been tested for COVID-19. Patient was recovering from the events, at the time of the report.
fever, cough, nasal congestion, runny nose, sore throat, body aches, chills, decreased taste, decreased smell, headache, shortness of breath with positive COVID PCR on 7/31/21
Itching followed by swelling and pain over the next 4 days with significant swelling from crease of anterior hip to just distal to patella.  Warmth / pain and antalgic gait noted.
Extreme fatigue, labored breathing, hyperventilation, numb fingers and toes, inability to speak, fever, backache, body aches.  Was at work at time symptoms began and workplace was going to call ambulance, but instead called parents to pick him up to take to emergency room/urgent care.
pt recv vax 3NOV97 & 5NOV97 pt exp an inj site rxn described as 2x2 in size erythematous & hot to touch;
A 49-year-old female patient, who has medical condition of hyperlipidemia for which she takes ZOCOR, had received a left deltoid booster dose of DECAVAC (lot number U2032CA) on 13 January 2009. two days post vaccination; the patient experienced swelling of the entire left arm and has joint pain. The patient was evaluated by a physician and prescribed ibuprofen and over the counter BENADRYL. No relevant diagnostic testes or laboratory data were performed. The patient recovered three to five days after onset of the adverse events. Follow-up information received  09 February 2009 from a health care professional who confirmed the patient had no illness at the time of vaccination. No additional information was provided at the time of the report. Documents held by sender: None. The reporter for this case is the same as for case 2009-00245.
Numbness in left fingertips remainder of day on 31 Dec 2021 Redness in injection area, size of a tennis ball and rash in the outer area shoulder, neck and back and hand shooting pain on described areas Size of injection site   still the same size at this time 1 January 2021 in addition to experiencing upper shoulder spasms at this time
patient is 17 years 6 months old.  Patient received Pfizer booster dose.
Caught Covid; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Caught Covid) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Caught Covid). At the time of the report, COVID-19 (Caught Covid) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       Concomitant medications were not reported.  Treatment information was not reported.  Company comment: This is a spontaneous case concerning a unspecified age female patient with no medical history reported, who experienced unexpected non-serious  event of covid-19, which occurred unspecified days after a dose (dose number not specified) of mRNA-1273 vaccine. Current ongoing pandemic remains as a confounder. The benefit-risk relationship of mRNA-1273 is not affected.   This case was linked to MOD-2022-576695 (Patient Link).  Sender's Comments: This is a spontaneous case concerning a unspecified age female patient with no medical history reported, who experienced unexpected non-serious  event of covid-19, which occurred unspecified days after a dose (dose number not specified) of mRNA-1273 vaccine. Current ongoing pandemic remains as a confounder. The benefit-risk relationship of mRNA-1273 is not affected.
headache, difficulty swollowing, increaase in saliva and mucas became thicker. Headache increased and eyes became burning and a sore throat started.
Started feeling muscle soreness about 10 hours post-injection, took an Advil, then woke up in the middle of the night to moderate muscle and joint pain and fatigue and nausea. Took another Advil.
"COVID Arm": Itchy, red, swollen, firm circular area around shot area. Originally occurred DAY OF shot, lasted 2 days and went away. Suddenly resurfaced 8 days later. Appox 3 inches in diameter. No other symptoms.  Ibuprofen taken for discomfort/heat of area. No other treatment.
On 2/13/01, noted thigh was red, swollen and warm. Seen on 2/14/01 and treated with ibuprofen and Keflex.
This spontaneous report as received from a nurse refers to a currently 76-year-old female patient with no drug reactions or allergies and with no medical history. On 07-NOV-2011, the patient was vaccinated with a dose of ZOSTAVAX injection (lot # 669745/0759AA with expiry date: 18-NOV-2011; strength, dose and route of administration unspecified). Concomitant therapies included fish oil, baby aspirin, OS-CAL, vitamin D and atenolol. The nurse reported that the patient developed shingles twice since the vaccination. The first episode of shingles occurred on an unspecified date, the patient received unspecified treatment and recovered on an unspecified date. Then, the patient was seen in the physician's office on 31-MAR-2015 (reported as: yesterday), she sought medical attention due to second episode of shingles. No laboratory tests were performed. The patient was prescribed acyclovir 800 mg, 5 times daily for the next 7 days, along with TYLENOL and ibuprofen (unspecified doses as needed). The nurse reported that the patient had not recovered from the second episode of shingles. The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
Patient reports experiencing high fever, breathing trouble, chest pain, low blood pressure, headache, and fatigue starting about 3 hours after receiving the vaccine and lasting for about a week. She is feeling much better but still not 100% better.
Around 12 hours after vaccine given patient experienced shivering/vomiting/diarrhea and general weakness. Experience these symptoms with the initial SHINGRIX 9/7/18 (which was coadministered with FLUZONE HD.
Mom discovered left leg swollen in AM on 2/7 when changing her diaper. Mom reported hot, red and 2-3 times normal size. Instructed to try Motrin/Tylenol/warm baths and if not better or still worried ER. She called on her own doctor 200 miles away. This was on 2/7 that she called about this. 2/11/03 PC back to home and spoke with mom's step mother who said mom took child and disappeared. Mom was to have entered rehab today. Onset morning of 02/07/2003
Bronchitis; This spontaneous case was reported by a consumer and describes the occurrence of BRONCHITIS (Bronchitis) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included INSULIN HUMAN (NOVOLIN R) and INSULIN HUMAN INJECTION, ISOPHANE (NOVOLIN N) for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BRONCHITIS (Bronchitis). At the time of the report, BRONCHITIS (Bronchitis) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Negative) Patient's COVID-19 test results were negative.. On an unknown date, Streptococcus test: (Negative) Patient's Strep test results were negative..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication information was reported. The patient said that the vaccine had nothing to do with the bronchitis and she reported her doctor also said the same. Patient was scheduled to have a Cortisone shot as treatment but her doctor canceled the appointment as it conflicted with her second vaccine shot which was on same day.
This non-serious consumer report (initial receipt 14-Oct-2014) concerns a 69 year old female patient who received the flu shot for the past ten years. The patient visits her doctor annually for check ups. On the 20-Sep-2014, the patient received AFLURIA (batch number not reported) for the prevention of influenza in the left arm. About three weeks prior to the 14-Oct-2014, the patient developed sharp pains across the back shoulder when lying down. The patient described it as a twang. The patient was not horrible and was not a big deal however did not go away. Initially the patient thought the she had slept in an awkward position but knew something was wrong because her back muscles continued to feel sore. Recently, the pain left her back region and radiated down her left arm towards her fingertips. Treatment included topical BENGAY to treat the pain at night only which somewhat helped. When putting on a shirt, she only used her right arm because she felt sharp pain when raising the left arm above her head. This is the first time she has experienced this after the flu shot. Outcome was not recovered.